Leukocytoreduction for acute leukemia

Therapeutic Apheresis

Volumn 6, Issue 1, 2002, Pages 15-23

  Porcu, Pierluigi ^a,b   Farag, Sherif ^a   Marcucci, Guido ^a   Cataland, Spero R ^a   Kennedy, Melanie S ^a   Bissell, Michael ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Acute leukemia; Hyperleukocytosis; Leukapheresis; Leukostasis

Indexed keywords

CELL ADHESION MOLECULE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; BRAIN HEMORRHAGE; CANCER MORTALITY; CHEMOTAXIS; ENDOTHELIUM INJURY; HUMAN; LEUKAPHERESIS; LEUKOCYTOSIS; LEUKOSTASIS; METABOLIC DISORDER; PRIORITY JOURNAL; RESPIRATORY FAILURE;

ACUTE DISEASE; ADULT; HUMANS; LEUKAPHERESIS; LEUKEMIA; LEUKOCYTOSIS; LEUKOSTASIS;

EID: 0036118416     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00402.x     Document Type: Article

References (99)

1. Hyperleukocytic leukemias: A review of pathophysiology, clinical presentation and management
2. Therapy for acute myeloid leukemia
3. Clinical manifestations of acute lymphocytic leukemia
4. A distinctive type of intracerebral hemorrhage associated with blast crisis in patients with leukemia
5. The association of fatal intracranial hemorrhage and blastic crisis in patients with acute leukemia
6. Indications for emergency apheresis procedures
7. Rapid cytoreduction in acute leukemia. Management of cerebral leukostasis by cell pheresis
8. Reversible respiratory failure due to intravascular leukostasis in chronic myelogenous leukemia
9. Chronic granulocytic leukemia with respiratory distress. Efficacy of emergency leukapheresis
10. Continuous flow leukapheresis for rapid cytoreduction in leukemia
11. Hyperleukocytic retinopathy in chronic granulocytic leukemia: The role of intensive leukapheresis
12. Hyperleukocytosis in adult acute non-lymphocytic leukemia: Impact on remission rate and duration and survival
13. Clinical course and response to treatment of patients with AML presenting with a high leukocyte count
14. Factors affecting survival of patients with acute myelocytic leukemia presenting with high WBC counts
15. Therapeutic leukapheresis in hyperleukocytic leukemias: Lack of correlation between degree of cytoreduction and early mortality rate
16. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Association with hyperleukocytosis and acute monocytic leukemia
17. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute non-lymphoblastic leukemia
18. Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia
19. Acute myeloblastic leukemia with hyperleukocytosis: Risk factors for early mortality in induction
20. Biology and therapeutic implications of infant leukemia
21. Association with monocytic leukemia in patients with extreme leukocytosis
22. Diagnostic and prognostic factors in acute monocytic leukemia: An analysis of 51 cases
23. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PML/RAR isoform, and CD13 expression in patients treated with all-trans-retinoic acid
24. Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute non-lymphocytic leukemia. A new association
25. Clinical and hematological characteristics in acute leukemia with 11q23 translocations
26. Clinical and biological characteristics of adult de-novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: Confirmation of the existence of different entities with 11q23 breakpoint
27. Molecular biology of leukemias
28. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: A Southwest Oncology Group study
29. Use of recombinant granulocyte-macrophage colony stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): Final report of AML-11
30. Analysis of prognostic factors in acute lymphoblastic leukemia
31. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
32. Early death in acute leukemia in children
33. Frequency of early death in children with acute leukemia presenting with hyperleukocytosis
34. 3
35. Complications and outcome of childhood acute lymphoblastic leukemia with hyperleukocytosis
36. The effect of the initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia
37. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases
38. Hematologic malignancies with t(4;11)(q21;q23): A cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases
39. Philadelphia chromosome-positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A pediatric Oncology Group study
40. p16 gene homozygous deletions in acute lymphoblastic leukemia
41. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features
42. Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphoblastic leukemia
43. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group
44. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia
45. Intravascular thrombi and aggregates as a cause of morbidity and mortality in leukemia
46. Leukostasis, an underestimated cause of death in leukemia
47. Pulmonary leukostasis without hyperleukocytosis: A clinicopathologic study of 16 cases
48. Rheology of leukocytes, leukocyte suspensions, and blood in leukemia
49. Effect of high concentrations of leukocytes on whole blood viscosity
50. Leukostasis associated with blood transfusion in acute myeloid leukemia
51. Development of pulmonary leukostasis in experimental myelocytic leukemia in the Brown-Norway rat
52. Endothelial activation antigens in pulmonary leukostasis in leukemia
53. Endothelial cell activation by myeloblasts: Molecular mechanisms of leukostasis and leukemic cell dissemination
54. Expression and function of adhesion receptors in acute myelogenous leukemia: Parallels with normal erythroid and myeloid progenitors
55. Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts
56. Differential expression of adhesion molecules in acute leukemia
57. Regulation of leukocyte adhesion molecule-1 (TQ1, Leu-8) expression and shedding by normal and malignant cells
58. Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: Relationship with initial clinical characteristics and prognosis
59. Expression of intercellular adhesion molecule-I 1 (ICAM-1) in childhood acute lymphoblastic leukemia: Correlation with clinical features and outcome
60. Acute myeloid leukemia blast cells bind to human endothelium in vitro utilizing E-selectin and vascular cell adhesion molecule-1 (VCAM)
61. The molecular basis of leukocytosis
62. The roles of P-selectin and ICAM-1 in acute lung injury as determined using anti-adhesion molecule antibodies and mutant mice
63. The role of ICAM-1 in endotoxin-induced pneumonia evaluated using ICAM-1 antisense, anti-ICAM-1 antibodies and ICAM-1 mutant mice
64. Pulmonary leukostasis: Radiologic pathologic study
65. Explanation for the apparent hypoxemia associated with extreme leukocytosis: Leukocytic oxygen consumption
66. Hypoxemia in patients with hyperleukocytosis: True, spurious, and clinical implications
67. A prospective ophthalmologic evaluation of patients with acute myeloid leukemia: Correlation of ocular and hematological findings
68. Renal vein thrombosis complicating acute myeloid leukemia with hyperleukocytosis
69. Acute leg ischemia as a presentation of hyperleukocytosis syndrome in acute myeloid leukemia
70. Acute leg ischemia as a manifestation of the hyperleukocytosis syndrome in acute myeloid leukemia
71. Spurious elevation of the platelet count in acute leukemia
72. Respiratory failure due to leukostasis in leukemia
73. Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis
74. Respiratory distress of hyperleukocytic granulocytic leukemias
75. Therapeutic cytapheresis and plasma exchange
76. Managing the problem of hyperleukocytosis in acute leukemia
77. Management of hematological disorders and cancer
78. Respiratory failure due to pulmonary leukostasis following chemotherapy of acute non-lymphocytic leukemia
79. Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils
80. Leukemic cell lysis pneumopathy after chemotherapy: Acomplication of treated myeloblastic leukemia
81. Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis. A clinicopathologic report of four cases
82. Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia
83. Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia
84. Acute cytoreduction techniques in the early treatment of hyperleukocytosis associated with childhood hematological malignancies
85. Cytoreductive procedures in the early management of cases of leukemia and hyperleukocytosis in children
86. Therapeutic leukapheresis of acute myelo-monocytic leukemia in pregnancy
87. Leukapheresis reduces early risk of mortality in acute myeloid leukemia (AML) patients receiving first induction therapy
88. Improvement of leukemic hyperleukocytosis with only fluid and allopurinol therapy
89. Management of leukemic hyperleukocytosis with hydration, urinary alkalinization and allopurinol. Are cranial irradiation and invasive cytoreduction necessary?
90. Rapid cytoreduction in childhood leukemic hyperleukocytosis by conservative therapy
91. Central nervous system leukostasis in patients with leukemias and lymphomas
92. Acute lymphoblastic leukemia with hyperleukocytosis (HL) and supratentorial hemorrhage treated with leukapheresis
93. Neuropsychological effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer
94. The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocytes
95. Glucocorticoid receptor regulates the expression of L-selectin and CD11/CD18 on human neutrophils
96. Secreted glucocorticoids regulate leukocyte-endothelial interactions in inflammation
97. A mechanism for the anti-inflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1
98. Inhibition of leukocyte adhesion: An alternative mechanism of action for anti-inflammatory drugs
99. Glucocorticoid-induced granulocytosis: Contribution of marrow release and demargination of intravascular granulocytes